Cancer Research Annual Meeting 2010  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 5074s-5079s, September 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenberg, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenberg, S. A.

Immunotherapy and Gene Therapy of Cancer1

Steven A. Rosenberg

National Cancer Institute, Bethesda, Maryland 20892

In the past decade, immunotherapies have been developed that are capable of causing prolonged cancer regressions in selected patients with advanced metastatic disease. In the past year, attempts at the gene therapy of cancer have begun. These experimetnal cancer treatments deserve vigorous exploration.




This article has been cited by other articles:


Home page
J. Immunol.Home page
B. Linard, S. Bezieau, H. Benlalam, N. Labarriere, Y. Guilloux, E. Diez, and F. Jotereau
A ras-Mutated Peptide Targeted by CTL Infiltrating a Human Melanoma Lesion
J. Immunol., May 1, 2002; 168(9): 4802 - 4808.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
O. Utermohlen, C. Schulze-Garg, G. Warnecke, R. Gugel, J. Lohler, and W. Deppert
Simian Virus 40 Large-T-Antigen-Specific Rejection of mKSA Tumor Cells in BALB/c Mice Is Critically Dependent on both Strictly Tumor-Associated, Tumor-Specific CD8+ Cytotoxic T Lymphocytes and CD4+ T Helper Cells
J. Virol., November 15, 2001; 75(22): 10593 - 10602.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. L. Costa, J. M. Benson, C. M. Seroogy, P. Achacoso, C. G. Fathman, and G. P. Nolan
Targeting Rare Populations of Murine Antigen-Specific T Lymphocytes by Retroviral Transduction for Potential Application in Gene Therapy for Autoimmune Disease
J. Immunol., April 1, 2000; 164(7): 3581 - 3590.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. I. Ceballos, R. Ruiz-Maldonado, and M. C. Mihm
Melanoma in Children
N. Engl. J. Med., March 9, 1995; 332(10): 656 - 662.
[Full Text] [PDF]


Home page
Arch Fam MedHome page
C. J. Schmeichel and J. M. Loeb
Human Gene Therapy: A Role for the Primary Care Physician
Arch Fam Med, September 1, 1992; 1(1): 113 - 120.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.